IP Group

DiffBlue Limited is a developer of artificial intelligence software focused on automating coding tasks, particularly in Java development. Established in 2016 and based in Oxford, United Kingdom, the company specializes in automated testing software that generates unit tests autonomously. DiffBlue's technology leverages reinforcement learning to create fully formed tests that compile and run successfully, addressing one of the most challenging aspects of software development—writing unit tests. In addition to test generation, the company's software aids in bug fixing, refactoring code, translating programming languages, and enhancing security by identifying and rectifying vulnerabilities. DiffBlue's solutions not only save developers time but also provide valuable insights into test coverage, code testability, complexity, dependencies, and code churn, ultimately transforming the software writing process.

Alesi Surgical Ltd. is a company based in Cardiff, United Kingdom, specializing in the development and commercialization of laparoscopic surgical smoke handling systems. Founded in 2009 as a spin-out from the Welsh Institute for Minimal Access Therapy, Alesi Surgical focuses on creating products that enhance the safety, efficiency, and outcomes of surgical procedures. Its innovative tools are portable and suitable for both laparoscopic and robot-assisted surgeries, utilizing electrostatic precipitation technology to eliminate surgical smoke and maintain a clear visual field during operations. The company distributes its products to hospitals across Europe, the Middle East, New Zealand, and Australia, leveraging its access to experienced surgeons and surgical trainers to identify challenges in surgical procedures and design effective solutions.

Enterprise Therapeutics Ltd. is a drug discovery company based in Brighton, United Kingdom, established in 2014. The company is dedicated to researching and developing innovative therapies for respiratory diseases, particularly chronic obstructive pulmonary disease (COPD), cystic fibrosis, and asthma. Its focus is on creating disease-modifying treatments that address the underlying mechanisms of mucus congestion in the lungs, which can lead to breathing difficulties and increase the risk of lung infections. By targeting these mechanisms, Enterprise Therapeutics aims to improve the quality of life for patients suffering from these debilitating conditions.

AccelerComm Ltd is a semiconductor IP-core company based in Southampton, United Kingdom, specializing in Forward Error Correction (FEC) and channel coding solutions for wireless communications. Founded in 2016, the company develops advanced error correction technologies, including Polar and Turbo Decoders, as well as LDPC encoding and decoding chains, which are compliant with 3GPP standards. These technologies are designed to enhance the performance of next-generation wireless communication systems, addressing challenges such as noise, interference, and poor signal quality. By offering innovative solutions that improve the efficiency and reliability of communication networks, AccelerComm aims to support the evolution of mobile technology beyond 3G and 4G standards.

Deep Render Ltd. is a London-based AI startup that specializes in developing advanced media compression algorithms. Originating as a spin-out from the Department of Computing at Imperial College London, the company focuses on leveraging proprietary and patented technology to enhance media compression through deep learning techniques. Its innovative approach includes the application of density estimation, unsupervised learning, and quantum methods, resulting in state-of-the-art Biological Image Compression that achieves a minimum of 50% efficiency improvement over existing standards. Additionally, Deep Render is recognized for creating the first AI codec capable of real-time video playback, which allows for enhanced market opportunities and significant cost reductions for users.

AudioScenic Limited, founded in 2017 and headquartered in Southampton, United Kingdom, specializes in developing innovative 3D audio technology that enhances the listening experience across various industries including cinema, gaming, production, automotive, and public displays. The company utilizes small arrays of speakers combined with advanced head-tracking technologies to create controlled and independent sound beams directed to each ear, effectively simulating a virtual headphone experience without the need for traditional headphones or extensive speaker setups. This approach delivers a more authentic and immersive audio experience, allowing sounds to be perceived in three-dimensional space with remarkable clarity. AudioScenic’s technology eliminates the limitations of conventional loudspeaker systems by providing optimized sound delivery that adapitates to the listener's position. Their proprietary Virtua 3D Engine enables wide-ranging applications and cost-effective implementations, offering detailed acoustic design support to partners and customers in various market segments.

DiffBlue Limited is a developer of artificial intelligence software focused on automating coding tasks, particularly in Java development. Established in 2016 and based in Oxford, United Kingdom, the company specializes in automated testing software that generates unit tests autonomously. DiffBlue's technology leverages reinforcement learning to create fully formed tests that compile and run successfully, addressing one of the most challenging aspects of software development—writing unit tests. In addition to test generation, the company's software aids in bug fixing, refactoring code, translating programming languages, and enhancing security by identifying and rectifying vulnerabilities. DiffBlue's solutions not only save developers time but also provide valuable insights into test coverage, code testability, complexity, dependencies, and code churn, ultimately transforming the software writing process.

Kale United AB, founded in 2018 and headquartered in Stockholm, Sweden, specializes in providing advisory services to plant-based member companies. These services encompass marketing, public relations, sales and distribution, financing, community engagement, accounting, and human resources. The company focuses on supporting vegan startups and aims to foster growth within the plant-based food sector across the Nordic region.

Nexeon Limited is a battery materials and licensing company specializing in the development of silicon anodes for lithium-ion batteries. Founded in 2006 and headquartered in Abingdon, United Kingdom, with an additional office in Yokohama, Japan, Nexeon focuses on providing innovative silicon-based anode materials that enhance energy density and battery capacity. Its technology is applicable across various industries, including consumer electronics, electric vehicles, sustainable energy, aerospace, medical, and defense. By enabling lighter and more efficient batteries, Nexeon's solutions contribute to improved performance and longer lifetimes between charges, supporting the transition to sustainable energy and the achievement of net-zero goals. The company boasts a multidisciplinary technical team with diverse expertise, dedicated to advancing battery technology for a range of consumer and commercial markets.

Oxford Science Enterprises is a venture firm based in Oxford, United Kingdom, established in 2015 in partnership with the University of Oxford. The firm focuses on building and investing in companies that develop fundamental technologies aimed at addressing significant global challenges. Its investment areas include life sciences, healthcare, artificial intelligence, software, and deep tech, targeting issues such as nuclear fusion, quantum computing, and the development of treatments for infectious diseases. By leveraging its extensive experience and a robust network of investors, entrepreneurs, and sector experts, Oxford Science Enterprises aims to foster a world-class technology ecosystem and support the growth of innovative science-based businesses.

Abliva AB is a Swedish pharmaceutical company focused on the research and development of treatments for primary mitochondrial diseases, which are rare and severe conditions caused by dysfunctional mitochondria. The company's pipeline includes KL1333, currently in phase I clinical trials, and NV354, an energy replacement therapy that is preparing for clinical trials. KL1333 is noted for its role as a regulator of NAD+ and NADH, and has received orphan drug designation in both Europe and the United States. Additionally, Abliva is developing NeuroSTAT for the treatment of traumatic brain injury. Established in 2000 and headquartered in Lund, Sweden, Abliva has formed collaborations with various institutions, enhancing its research capabilities and clinical development efforts.

MoA Technology Ltd. is a plant genetics company based in Leeds, United Kingdom, that was spun out from the University of Oxford in 2017. The company focuses on developing innovative agricultural technologies aimed at enhancing sustainable crop systems. Led by Professor Liam Dolan, FRS, MoA Technology employs a unique approach to facilitate the production of healthy food, thereby supporting farmers in their efforts to cultivate crops sustainably.

SLAMcore Limited is a London-based company specializing in advanced simultaneous localization and mapping (SLAM) solutions tailored for augmented reality, robotics, and autonomous vehicles. Founded in 2016, SLAMcore develops software that enables devices with outward-looking sensors to accurately localize, navigate, and comprehend unfamiliar environments. Their offerings include Visual SLAM, sensor fusion techniques, and Event Camera SLAM, which facilitates incremental tracking and mapping from event camera data. By leveraging spatial artificial intelligence, the company fuses information from various sensors to create a cohesive understanding of surroundings, optimizing performance while reducing energy consumption. Through its software development kit (SDK), SLAMcore supports rapid prototyping and customization for commercial applications in industrial and consumer robotics, positioning its technology as a critical component in advancing the integration of robotic solutions into daily life.

GripAble Ltd. is a London-based company founded in 2017 that specializes in the development of digital therapy devices aimed at improving rehabilitation for individuals with movement impairments. The company’s flagship product, the GripAble Digital Handgrip, is a sensitive, portable device that wirelessly connects to a mobile application. This app allows users to engage in interactive therapy games designed to facilitate the assessment and training of hand and arm functions. GripAble's solutions target patients suffering from conditions such as stroke, arthritis, cerebral palsy, and trauma, addressing the challenges faced by over 500 million people globally who experience impaired arm mobility. By combining hardware with gamified therapy, GripAble enhances patient engagement and enables effective self-training both in clinical settings and at home.

First Light Fusion Limited is a UK-based company that specializes in researching advanced implosion processes aimed at electricity generation through inertial confinement fusion. Founded in 2011 as a spin-out from the University of Oxford, the company focuses on harnessing fundamental physics to explore various innovative energy generation methods. It employs a team of engineers and physicists who engage in theoretical analysis, detailed numerical simulations, and experimental validation to develop new energy sources. First Light Fusion collaborates closely with several academic institutions, including the University of Oxford, Warwick University, University College London, and Imperial College London. The company, originally named Oxyntix Ltd., rebranded in June 2014 to reflect its focus on fusion energy research.

Bramble Energy Ltd. is a London-based company that designs, develops, and manufactures printed circuit board fuel cells (PCBFC), specifically proton exchange membrane fuel cells (PEMFCs). Founded in 2016, the company utilizes innovative PCB technology to create high-performance and cost-effective fuel cell stacks, including variants of 20 W, 500 W, and 5 kW, along with custom-designed options. By leveraging the capabilities of the global high-volume PCB industry, Bramble Energy stands out as the first fuel cell manufacturer with the capacity to produce gigawatts of fuel cell hardware, a feat that has eluded the battery industry for years. The company's products serve various sectors, including stationary, portable, and automotive applications, offering businesses and energy industry players access to efficient solutions that help reduce energy consumption and lower carbon emissions.

DiffBlue Limited is a developer of artificial intelligence software focused on automating coding tasks, particularly in Java development. Established in 2016 and based in Oxford, United Kingdom, the company specializes in automated testing software that generates unit tests autonomously. DiffBlue's technology leverages reinforcement learning to create fully formed tests that compile and run successfully, addressing one of the most challenging aspects of software development—writing unit tests. In addition to test generation, the company's software aids in bug fixing, refactoring code, translating programming languages, and enhancing security by identifying and rectifying vulnerabilities. DiffBlue's solutions not only save developers time but also provide valuable insights into test coverage, code testability, complexity, dependencies, and code churn, ultimately transforming the software writing process.

Navenio Limited is a software technology company based in Oxford, United Kingdom, specializing in location-based services for indoor environments through mobile applications. Established in 2015, Navenio's innovative platform enhances indoor localization without the need for additional hardware, such as beacons or Wi-Fi. By utilizing advanced techniques like fingerprinting of the electromagnetic spectrum and indoor mapping, Navenio's solutions enable clients across various sectors, including retail, transportation, venues, and healthcare, to efficiently locate individuals and improve workforce productivity. The company's intelligent workforce solution automates processes based on established best practices, leading to significant enhancements in staff efficiency and operational workflows.

Ieso Digital Health Ltd. is a United Kingdom-based company specializing in online evidence-based mental health therapy. Founded in 2000 and formerly known as PsychologyOnline.co.uk Limited, Ieso provides a platform for one-to-one therapy sessions, allowing patients to engage with accredited therapists in a virtual environment tailored to their schedules. The company addresses a variety of mental health conditions, including anxiety, depression, eating disorders, and relationship issues, as well as chronic physical health problems and cognitive impairments. Utilizing cognitive behavioral therapy (CBT), Ieso employs proprietary technology enhanced by natural language processing and artificial intelligence to facilitate real-time monitoring and improve therapeutic outcomes. Its services cater to a diverse clientele, including health providers, private individuals, and businesses, aiming to transform the landscape of mental healthcare through scalable digital products and therapeutics.

Ieso Digital Health Ltd. is a United Kingdom-based company specializing in online evidence-based mental health therapy. Founded in 2000 and formerly known as PsychologyOnline.co.uk Limited, Ieso provides a platform for one-to-one therapy sessions, allowing patients to engage with accredited therapists in a virtual environment tailored to their schedules. The company addresses a variety of mental health conditions, including anxiety, depression, eating disorders, and relationship issues, as well as chronic physical health problems and cognitive impairments. Utilizing cognitive behavioral therapy (CBT), Ieso employs proprietary technology enhanced by natural language processing and artificial intelligence to facilitate real-time monitoring and improve therapeutic outcomes. Its services cater to a diverse clientele, including health providers, private individuals, and businesses, aiming to transform the landscape of mental healthcare through scalable digital products and therapeutics.

Ultraleap Limited is a leading developer of mid-air haptic control systems and 3D hand tracking technology. Formerly known as Ultrahaptics, the company specializes in creating solutions that utilize ultrasound to generate tactile sensations, enabling users to feel three-dimensional shapes and textures without physical contact. Its flagship products include the Leap Motion Controller, which captures hand movements, and the VR Developer Mount, designed for enhancing virtual reality experiences on various headsets. The company's innovative technology is applicable across multiple industries such as extended reality, automotive, digital signage, industrial automation, consumer electronics, and location-based entertainment. Established in 2013 and headquartered in Bristol, United Kingdom, Ultraleap also has a subsidiary in Silicon Valley, United States.

Monolith AI Limited is a software company based in London, United Kingdom, founded in 2016. The company specializes in developing algorithms that integrate engineering simulations with machine learning techniques to enhance the engineering design process. By leveraging existing simulation and test data, Monolith AI enables engineers to predict the behavior of new products more accurately, thereby optimizing research and development efforts. This approach reduces the need for extensive simulations, tests, and prototypes, allowing companies to accelerate product development and improve overall product quality. Monolith AI was previously known as UQuant Limited until it rebranded in June 2018.

Alesi Surgical Ltd. is a company based in Cardiff, United Kingdom, specializing in the development and commercialization of laparoscopic surgical smoke handling systems. Founded in 2009 as a spin-out from the Welsh Institute for Minimal Access Therapy, Alesi Surgical focuses on creating products that enhance the safety, efficiency, and outcomes of surgical procedures. Its innovative tools are portable and suitable for both laparoscopic and robot-assisted surgeries, utilizing electrostatic precipitation technology to eliminate surgical smoke and maintain a clear visual field during operations. The company distributes its products to hospitals across Europe, the Middle East, New Zealand, and Australia, leveraging its access to experienced surgeons and surgical trainers to identify challenges in surgical procedures and design effective solutions.

Oxford Nanopore Technologies Limited is a biotechnology company specializing in the development and commercialization of nanopore-based sequencing technology for the analysis of DNA, RNA, proteins, and small molecules. Its innovative product lineup includes the portable MinION device, the benchtop PromethION, and the GridION system, all of which enable real-time data streaming and scalable sequencing for a variety of applications in scientific research, personalized medicine, environmental monitoring, and agriculture. The Flongle offers smaller, on-demand sequencing solutions, catering to users requiring rapid insights. Operating in over 80 countries, Oxford Nanopore's technology is designed for accessibility and ease of use, featuring straightforward library preparation and automated solutions. The company maintains a robust patent portfolio, supporting its ongoing research and development in both biological and solid-state nanopore technologies. Founded in 2005 and based in Oxford, United Kingdom, Oxford Nanopore Technologies also has offices in multiple countries, including the United States, China, and Germany.

Oxular Limited is a clinical-stage company based in Oxford, United Kingdom, focused on developing innovative retinal treatments aimed at addressing various retinal diseases. Founded in 2014, the company specializes in tissue-specific drug delivery technologies designed to enhance the effectiveness of treatments for conditions such as age-related macular degeneration, diabetic macular edema, retinal vein occlusion, and cystoid macular edema. By targeting specific areas within the eye, Oxular aims to improve patient outcomes, reduce side effects, and decrease the frequency of treatments required. The company is committed to transforming the landscape of retinal therapeutics and providing life-changing solutions for patients facing unmet medical needs.

C-Capture Limited is a company based in Leeds, United Kingdom, founded in 2008, specializing in the development and design of solvent systems for the removal of carbon dioxide (CO2) from gas streams. The firm employs a bottom-up approach to create proprietary carbon capture solvent technology that targets the economic and non-toxic extraction of CO2 from emission sources. This technology is particularly aimed at post-combustion capture processes in power generation and hard-to-abate industries, addressing the significant role of CO2 as a greenhouse gas and its contribution to global warming. By providing absorbents and solvents, C-Capture supports the implementation of carbon capture and storage (CCS), promoting environmentally sustainable electricity generation.

Econic Technologies Ltd. is a chemical technology company based in Macclesfield, United Kingdom, specializing in the development of innovative processes to convert carbon dioxide and epoxides into valuable polymers and polyurethanes. Founded in 2011, the company leverages catalyst chemistry to transform waste CO2 into commercially viable products, thereby reducing dependence on fossil fuels and providing environmental benefits. Econic's product offerings include polycarbonates and polycarbonate polyols, which are utilized in various applications such as mattresses, insulation, footwear, packaging, and construction materials. Additionally, the company produces glues and coatings for industrial uses. With patented catalyst technologies and a skilled team of scientists and engineers, Econic Technologies operates from a state-of-the-art facility at Alderley Park, focusing on turning scientific advancements into practical solutions for the plastics industry while addressing environmental challenges.

AudioScenic Limited, founded in 2017 and headquartered in Southampton, United Kingdom, specializes in developing innovative 3D audio technology that enhances the listening experience across various industries including cinema, gaming, production, automotive, and public displays. The company utilizes small arrays of speakers combined with advanced head-tracking technologies to create controlled and independent sound beams directed to each ear, effectively simulating a virtual headphone experience without the need for traditional headphones or extensive speaker setups. This approach delivers a more authentic and immersive audio experience, allowing sounds to be perceived in three-dimensional space with remarkable clarity. AudioScenic’s technology eliminates the limitations of conventional loudspeaker systems by providing optimized sound delivery that adapitates to the listener's position. Their proprietary Virtua 3D Engine enables wide-ranging applications and cost-effective implementations, offering detailed acoustic design support to partners and customers in various market segments.

AccelerComm Ltd is a semiconductor IP-core company based in Southampton, United Kingdom, specializing in Forward Error Correction (FEC) and channel coding solutions for wireless communications. Founded in 2016, the company develops advanced error correction technologies, including Polar and Turbo Decoders, as well as LDPC encoding and decoding chains, which are compliant with 3GPP standards. These technologies are designed to enhance the performance of next-generation wireless communication systems, addressing challenges such as noise, interference, and poor signal quality. By offering innovative solutions that improve the efficiency and reliability of communication networks, AccelerComm aims to support the evolution of mobile technology beyond 3G and 4G standards.

Bramble Energy Ltd. is a London-based company that designs, develops, and manufactures printed circuit board fuel cells (PCBFC), specifically proton exchange membrane fuel cells (PEMFCs). Founded in 2016, the company utilizes innovative PCB technology to create high-performance and cost-effective fuel cell stacks, including variants of 20 W, 500 W, and 5 kW, along with custom-designed options. By leveraging the capabilities of the global high-volume PCB industry, Bramble Energy stands out as the first fuel cell manufacturer with the capacity to produce gigawatts of fuel cell hardware, a feat that has eluded the battery industry for years. The company's products serve various sectors, including stationary, portable, and automotive applications, offering businesses and energy industry players access to efficient solutions that help reduce energy consumption and lower carbon emissions.

IBEX Innovations Limited, established in 2010 and based in Sedgefield, UK, specializes in developing and commercializing advanced X-ray detector technology. The company's flagship product, IBEX multi absorption plate (MAP) technology, enhances standard X-ray detectors to generate high-sensitivity materials information while retaining key characteristics such as speed, signal-to-noise ratio, spatial resolution, and imaging area. IBEX Innovations serves diverse applications including bone mineral density measurement in medical diagnostics, electronics inspection, food safety, and security screening. The company collaborates with academic institutions like Durham University for technology development and NHS trusts for medical application validation. Backed by venture capital funding from Northstar Ventures, IP Group, Nordson Incorporated, Innovate UK, and the European Commission, IBEX Innovations aims to revolutionize X-ray imaging across various industries.

Navenio Limited is a software technology company based in Oxford, United Kingdom, specializing in location-based services for indoor environments through mobile applications. Established in 2015, Navenio's innovative platform enhances indoor localization without the need for additional hardware, such as beacons or Wi-Fi. By utilizing advanced techniques like fingerprinting of the electromagnetic spectrum and indoor mapping, Navenio's solutions enable clients across various sectors, including retail, transportation, venues, and healthcare, to efficiently locate individuals and improve workforce productivity. The company's intelligent workforce solution automates processes based on established best practices, leading to significant enhancements in staff efficiency and operational workflows.

Mixergy Ltd, founded in 2014 and headquartered in Cassington, United Kingdom, specializes in the development of innovative energy storage solutions, particularly hot water tanks. The company's technology is designed to enhance energy efficiency and support the integration of renewable energy sources, such as solar power and heat pumps. By providing a cost-effective means to store and utilize energy, Mixergy aims to facilitate grid balancing and optimize the use of renewable power, contributing to a more sustainable energy landscape.

WaveOptics, Ltd. is a designer and manufacturer of advanced augmented reality display technology, specializing in diffractive waveguides for wearable devices. Founded in 2014 and headquartered in Abingdon-on-Thames, United Kingdom, the company focuses on providing key optical components for augmented reality applications. WaveOptics employs patented technology that utilizes waveguide holography and photonic crystals to create lightweight, high-performance displays. Their innovative designs feature a high field of view and full RGB color, allowing for an enriched user experience without the bulk typically associated with traditional augmented reality systems. The company has established strategic partnerships with leading firms such as Compal, Wistron, and Plessey to enhance its product offerings and market reach.

IBEX Innovations Limited, established in 2010 and based in Sedgefield, UK, specializes in developing and commercializing advanced X-ray detector technology. The company's flagship product, IBEX multi absorption plate (MAP) technology, enhances standard X-ray detectors to generate high-sensitivity materials information while retaining key characteristics such as speed, signal-to-noise ratio, spatial resolution, and imaging area. IBEX Innovations serves diverse applications including bone mineral density measurement in medical diagnostics, electronics inspection, food safety, and security screening. The company collaborates with academic institutions like Durham University for technology development and NHS trusts for medical application validation. Backed by venture capital funding from Northstar Ventures, IP Group, Nordson Incorporated, Innovate UK, and the European Commission, IBEX Innovations aims to revolutionize X-ray imaging across various industries.

Aqdot Limited is a company based in Cambridge, United Kingdom, that specializes in the manufacture of smart microcapsules through innovative fabrication technology. Founded in 2012, Aqdot's approach utilizes a one-step shrink-wrap method, integrating emulsion technology and supramolecular chemistry, to simplify the microencapsulation process. This technology is designed to create customizable microcapsules that serve various industries, including home care, beauty, and agrochemicals. It enables the protection and targeted release of valuable active ingredients, such as enzymes in laundry detergents and fertilizers in agriculture. Aqdot's energy-efficient production methods contribute to lower energy consumption and reduced waste, positioning the company within the multi-billion-dollar microencapsulation market, which has established applications across numerous sectors, including personal care, food, and agrochemicals.

Inivata Limited is a clinical cancer genomics company based in Cambridge, United Kingdom, that specializes in the analysis of circulating tumor DNA (ctDNA) to enhance cancer testing and treatment. Founded in 2014, Inivata has developed TAm-Seq technology, which enables the detection and analysis of genomic material from a patient's cell-free ctDNA, collected through non-invasive blood samples. This innovative approach, known as liquid biopsy, provides a significant advancement over traditional invasive biopsies by allowing for easier detection, monitoring, and treatment of cancer. Inivata's platform aims to assist oncologists in making informed treatment decisions by improving the understanding of cancer dynamics, including monitoring treatment responses and detecting relapses. The company has established a strategic collaboration with NeoGenomics, Inc. to further its mission in the field of cancer genomics.

AccelerComm Ltd is a semiconductor IP-core company based in Southampton, United Kingdom, specializing in Forward Error Correction (FEC) and channel coding solutions for wireless communications. Founded in 2016, the company develops advanced error correction technologies, including Polar and Turbo Decoders, as well as LDPC encoding and decoding chains, which are compliant with 3GPP standards. These technologies are designed to enhance the performance of next-generation wireless communication systems, addressing challenges such as noise, interference, and poor signal quality. By offering innovative solutions that improve the efficiency and reliability of communication networks, AccelerComm aims to support the evolution of mobile technology beyond 3G and 4G standards.

C-Capture Limited is a company based in Leeds, United Kingdom, founded in 2008, specializing in the development and design of solvent systems for the removal of carbon dioxide (CO2) from gas streams. The firm employs a bottom-up approach to create proprietary carbon capture solvent technology that targets the economic and non-toxic extraction of CO2 from emission sources. This technology is particularly aimed at post-combustion capture processes in power generation and hard-to-abate industries, addressing the significant role of CO2 as a greenhouse gas and its contribution to global warming. By providing absorbents and solvents, C-Capture supports the implementation of carbon capture and storage (CCS), promoting environmentally sustainable electricity generation.

AudioScenic Limited, founded in 2017 and headquartered in Southampton, United Kingdom, specializes in developing innovative 3D audio technology that enhances the listening experience across various industries including cinema, gaming, production, automotive, and public displays. The company utilizes small arrays of speakers combined with advanced head-tracking technologies to create controlled and independent sound beams directed to each ear, effectively simulating a virtual headphone experience without the need for traditional headphones or extensive speaker setups. This approach delivers a more authentic and immersive audio experience, allowing sounds to be perceived in three-dimensional space with remarkable clarity. AudioScenic’s technology eliminates the limitations of conventional loudspeaker systems by providing optimized sound delivery that adapitates to the listener's position. Their proprietary Virtua 3D Engine enables wide-ranging applications and cost-effective implementations, offering detailed acoustic design support to partners and customers in various market segments.

WaveOptics, Ltd. is a designer and manufacturer of advanced augmented reality display technology, specializing in diffractive waveguides for wearable devices. Founded in 2014 and headquartered in Abingdon-on-Thames, United Kingdom, the company focuses on providing key optical components for augmented reality applications. WaveOptics employs patented technology that utilizes waveguide holography and photonic crystals to create lightweight, high-performance displays. Their innovative designs feature a high field of view and full RGB color, allowing for an enriched user experience without the bulk typically associated with traditional augmented reality systems. The company has established strategic partnerships with leading firms such as Compal, Wistron, and Plessey to enhance its product offerings and market reach.

Ultraleap Limited is a leading developer of mid-air haptic control systems and 3D hand tracking technology. Formerly known as Ultrahaptics, the company specializes in creating solutions that utilize ultrasound to generate tactile sensations, enabling users to feel three-dimensional shapes and textures without physical contact. Its flagship products include the Leap Motion Controller, which captures hand movements, and the VR Developer Mount, designed for enhancing virtual reality experiences on various headsets. The company's innovative technology is applicable across multiple industries such as extended reality, automotive, digital signage, industrial automation, consumer electronics, and location-based entertainment. Established in 2013 and headquartered in Bristol, United Kingdom, Ultraleap also has a subsidiary in Silicon Valley, United States.

IBEX Innovations Limited, established in 2010 and based in Sedgefield, UK, specializes in developing and commercializing advanced X-ray detector technology. The company's flagship product, IBEX multi absorption plate (MAP) technology, enhances standard X-ray detectors to generate high-sensitivity materials information while retaining key characteristics such as speed, signal-to-noise ratio, spatial resolution, and imaging area. IBEX Innovations serves diverse applications including bone mineral density measurement in medical diagnostics, electronics inspection, food safety, and security screening. The company collaborates with academic institutions like Durham University for technology development and NHS trusts for medical application validation. Backed by venture capital funding from Northstar Ventures, IP Group, Nordson Incorporated, Innovate UK, and the European Commission, IBEX Innovations aims to revolutionize X-ray imaging across various industries.

Yoyo Wallet, established in 2013 and headquartered in London, specializes in mobile payment solutions. It offers a user-friendly app enabling customers to make in-store purchases using their smartphones, processing over 150,000 monthly transactions. The platform combines payment and loyalty features, providing retailers with a marketing tool for in-store customer engagement and targeted rewards based on purchase history. Yoyo Wallet serves retailers, universities, and corporate locations across the United Kingdom.

Garrison Technology Limited, established in London, UK, in 2014, specializes in enterprise cybersecurity solutions. The company focuses on developing innovative anti-malware technology designed to efficiently mitigate high-impact internet-borne targeted attacks, a significant threat to modern organizations. Garrison's unique approach enables secure internet connectivity, enhances user experience, and ensures scalability for enterprises.

Dukosi Ltd is a company that specializes in the design, development, and manufacture of advanced battery management systems, primarily serving the automotive industry. Founded in 2003 and located in Edinburgh, United Kingdom, Dukosi offers innovative cell sensor products tailored for hybrid, plug-in hybrid, and electric vehicles, as well as electric bicycles and mobility solutions. The company's technology enables real-time monitoring of individual battery cell health, contributing to enhanced performance and longevity. Dukosi's solutions are aimed at providing reliable and renewable energy sources for vehicles, transport networks, and various applications, thereby supporting the transition to cleaner energy technologies.

Artios Pharma Limited is a biotechnology company based in Cambridge, United Kingdom, that specializes in developing innovative cancer treatments targeting DNA damage response (DDR) pathways. Founded in 2016, the company is dedicated to creating first-in-class therapies that selectively kill cancer cells by exploiting their reliance on DDR mechanisms. Artios’ product pipeline includes a range of promising candidates, such as a therapy that targets DNA polymerase theta, a protein involved in DNA repair processes, and another program focusing on a novel DDR target. The company collaborates with prominent research organizations, including Cancer Research Technology, to enhance its development efforts and leverage expertise in DNA repair. Artios is led by a skilled team with extensive experience in drug discovery, positioning it to advance its next-generation DDR programs and contribute significantly to the field of cancer treatment.

Spirea Ltd is a healthcare technology company based in Harrogate, United Kingdom, focused on developing innovative antibody drug conjugates (ADCs) for cancer treatment. Established in 2015, Spirea has created a smart polymer platform that enhances the controlled delivery of drug combinations, aiming to maximize the clinical efficacy of therapies. The company's flexible approach to ADC design allows for a greater amount of drug payload to be precisely targeted at tumor cells, increasing therapeutic effects while significantly minimizing adverse side effects. This advancement enables healthcare providers to offer well-tolerated treatment options for a variety of cancer types, ultimately improving patient outcomes.

Enterprise Therapeutics Ltd. is a drug discovery company based in Brighton, United Kingdom, established in 2014. The company is dedicated to researching and developing innovative therapies for respiratory diseases, particularly chronic obstructive pulmonary disease (COPD), cystic fibrosis, and asthma. Its focus is on creating disease-modifying treatments that address the underlying mechanisms of mucus congestion in the lungs, which can lead to breathing difficulties and increase the risk of lung infections. By targeting these mechanisms, Enterprise Therapeutics aims to improve the quality of life for patients suffering from these debilitating conditions.

Econic Technologies Ltd. is a chemical technology company based in Macclesfield, United Kingdom, specializing in the development of innovative processes to convert carbon dioxide and epoxides into valuable polymers and polyurethanes. Founded in 2011, the company leverages catalyst chemistry to transform waste CO2 into commercially viable products, thereby reducing dependence on fossil fuels and providing environmental benefits. Econic's product offerings include polycarbonates and polycarbonate polyols, which are utilized in various applications such as mattresses, insulation, footwear, packaging, and construction materials. Additionally, the company produces glues and coatings for industrial uses. With patented catalyst technologies and a skilled team of scientists and engineers, Econic Technologies operates from a state-of-the-art facility at Alderley Park, focusing on turning scientific advancements into practical solutions for the plastics industry while addressing environmental challenges.

Spirea Ltd is a healthcare technology company based in Harrogate, United Kingdom, focused on developing innovative antibody drug conjugates (ADCs) for cancer treatment. Established in 2015, Spirea has created a smart polymer platform that enhances the controlled delivery of drug combinations, aiming to maximize the clinical efficacy of therapies. The company's flexible approach to ADC design allows for a greater amount of drug payload to be precisely targeted at tumor cells, increasing therapeutic effects while significantly minimizing adverse side effects. This advancement enables healthcare providers to offer well-tolerated treatment options for a variety of cancer types, ultimately improving patient outcomes.

Oxehealth Ltd. is a technology company based in Oxford, United Kingdom, that specializes in non-contact vital signs monitoring. Founded in 2012, it has developed the Oxecam software, which allows for the remote measurement of heart rate, respiratory rate, and blood oxygenation using digital video cameras. This innovative approach is particularly beneficial in medical settings, where it can enhance care for elderly and vulnerable individuals in environments where staff presence is limited. The system generates alerts for risky activities and provides objective data on patient vitals, enabling informed care planning. Oxehealth's technology combines proprietary algorithms that leverage deep learning, computer vision, and signal processing, making it suitable for various sectors, including healthcare, security, and retail. Its Digital Care Assistant supports clinicians and caregivers in mental health facilities, prisons, and home care, facilitating proactive interventions based on real-time data. Oxehealth is recognized for achieving the world’s first medical device certification for its software, demonstrating its commitment to enhancing patient care through innovative technology.

Navenio Limited is a software technology company based in Oxford, United Kingdom, specializing in location-based services for indoor environments through mobile applications. Established in 2015, Navenio's innovative platform enhances indoor localization without the need for additional hardware, such as beacons or Wi-Fi. By utilizing advanced techniques like fingerprinting of the electromagnetic spectrum and indoor mapping, Navenio's solutions enable clients across various sectors, including retail, transportation, venues, and healthcare, to efficiently locate individuals and improve workforce productivity. The company's intelligent workforce solution automates processes based on established best practices, leading to significant enhancements in staff efficiency and operational workflows.

Kudo Insurance is a developer of a mobile application designed to assess driving behavior and provide personalized car insurance solutions. The app evaluates users' driving habits through telematics, assigning an individual score that influences their insurance quotes. Users are incentivized for safe driving with Kudo Koins, a form of in-app currency that can be exchanged for goods or entries into cash prize draws. This gamified approach not only enhances user engagement but also encourages referrals and sustained app usage. The driving data collected may serve as evidence in the event of an accident, adding an extra layer of utility for users. With its innovative data science and risk selection techniques, Kudo aims to establish itself as a leading motor insurer, starting in the UK and planning to expand internationally within the next few years.

Touchstone Innovations is a venture capital firm that focuses on creating, building, and investing in pioneering technology companies emerging from exceptional scientific research in the 'Golden Triangle' of London, Cambridge, and Oxford. Established in 1986, the firm employs a comprehensive strategy that encompasses the entire process from idea generation to intellectual property protection, company formation, seed funding, incubation, and scale-up. By providing continuous investment from start-up to scale-up, Touchstone Innovations supports scientists and entrepreneurs in commercializing their ideas through licensing and recruitment of top management teams. The firm has a proven track record of leveraging early-stage research into high-quality, well-managed businesses, maintaining active involvement with its portfolio companies throughout their lifecycle. With a commitment to de-risking investment, Touchstone Innovations has facilitated over £1.5 billion in funding to drive technological innovation in the UK. In 2017, the firm was acquired by IP Group plc, further expanding its capabilities in the investment landscape.

Inductosense Ltd is a manufacturer based in Bristol, United Kingdom, specializing in wireless and battery-free sensors designed for the detection of cracks, corrosion, and defects in various structures and products. Founded in 2015, the company offers innovative solutions such as the WAND Evaluation System, which includes a set of sensors, a handheld measurement probe, and a sensor fixing kit for measuring structural thickness. Additionally, Inductosense develops TRND systems for monitoring internal corrosion and erosion in pipework and vessels. The sensors can be permanently affixed to surfaces and are capable of operating beneath coatings, insulation, or repairs. They utilize a passive technology that relies on non-contact inductive coupling to receive power and transmit signals, allowing for fast and repeatable inspections. Inductosense's products are applicable in the inspection of large structures, composite repairs, and remote monitoring, providing clients with reliable data for maintenance and safety assessments.

Eight19 Limited, based in Cambridge, United Kingdom, specializes in the development and manufacture of organic photovoltaic (OPV) modules designed for lightweight solar panels. Founded in 2010, the company focuses on providing energy harvesting solutions for various applications, including indoor, outdoor, and off-grid environments. Eight19's innovative use of roll-to-roll manufacturing processes and solution-based organic materials allows for cost-effective scaling of its technology. Their products are particularly suited for the internet of things, wireless devices, and portable electronics, offering benefits such as flexibility, thinness, and robustness. The company also produces integrated demonstration units, including Bluetooth-connected temperature and light sensors powered by its OPV modules, reinforcing its commitment to advancing sustainable energy solutions.

Creavo Medical Technologies Ltd. is a UK-based medical device company focused on developing innovative imaging technologies for acute medical settings. Incorporated in 2014, the company has its headquarters in Coventry and additional facilities in Leeds. Creavo specializes in creating portable, battery-powered devices that utilize magnetocardiography to detect heart-related issues, such as acute coronary syndromes and ischemia, directly at the patient's bedside. Founded by a team of clinical, research, and business experts, the company aims to improve diagnostic techniques and enhance patient outcomes in healthcare settings. Creavo Medical Technologies was previously known as Quantum Imaging Limited before rebranding in September 2016.

Alesi Surgical Ltd. is a company based in Cardiff, United Kingdom, specializing in the development and commercialization of laparoscopic surgical smoke handling systems. Founded in 2009 as a spin-out from the Welsh Institute for Minimal Access Therapy, Alesi Surgical focuses on creating products that enhance the safety, efficiency, and outcomes of surgical procedures. Its innovative tools are portable and suitable for both laparoscopic and robot-assisted surgeries, utilizing electrostatic precipitation technology to eliminate surgical smoke and maintain a clear visual field during operations. The company distributes its products to hospitals across Europe, the Middle East, New Zealand, and Australia, leveraging its access to experienced surgeons and surgical trainers to identify challenges in surgical procedures and design effective solutions.

Ultraleap Limited is a leading developer of mid-air haptic control systems and 3D hand tracking technology. Formerly known as Ultrahaptics, the company specializes in creating solutions that utilize ultrasound to generate tactile sensations, enabling users to feel three-dimensional shapes and textures without physical contact. Its flagship products include the Leap Motion Controller, which captures hand movements, and the VR Developer Mount, designed for enhancing virtual reality experiences on various headsets. The company's innovative technology is applicable across multiple industries such as extended reality, automotive, digital signage, industrial automation, consumer electronics, and location-based entertainment. Established in 2013 and headquartered in Bristol, United Kingdom, Ultraleap also has a subsidiary in Silicon Valley, United States.

SAW DX Ltd is a technology development company based in Glasgow, United Kingdom, that specializes in designing and manufacturing point-of-care (POC) diagnostic devices. The company leverages innovative Acoustic-Flow technology, which utilizes surface acoustic waves to drive diagnostic tests by manipulating fluid movement and microstructures on disposable chips. This approach allows for on-chip sample processing without the need for preprocessing, streamlining the diagnostic process. SAW DX's product offerings include prototypes for diagnosing sexually transmitted infections, demonstrator readers and cartridges for tuberculosis assays, and platforms for enriching parasites and performing molecular detection with low-cost disposable chips. The company primarily serves life sciences and diagnostics organizations seeking to enhance their diagnostic capabilities through advanced POC solutions. Incorporated in 2013, SAW DX aims to provide faster, more efficient, and cost-effective diagnostic methods for infectious diseases.

Dukosi Ltd is a company that specializes in the design, development, and manufacture of advanced battery management systems, primarily serving the automotive industry. Founded in 2003 and located in Edinburgh, United Kingdom, Dukosi offers innovative cell sensor products tailored for hybrid, plug-in hybrid, and electric vehicles, as well as electric bicycles and mobility solutions. The company's technology enables real-time monitoring of individual battery cell health, contributing to enhanced performance and longevity. Dukosi's solutions are aimed at providing reliable and renewable energy sources for vehicles, transport networks, and various applications, thereby supporting the transition to cleaner energy technologies.

Parkwalk Advisors, established in 2009 and headquartered in London, is a venture capital firm specializing in investing in UK-based technology companies spun out from universities. The firm focuses on sectors such as AI, big data, life science, materials, cleantech, medtech, and quantum computing, typically investing between £2.5 million and £10 million. Parkwalk seeks to generate capital gains for its investors, enhanced by attractive tax reliefs like the Enterprise Investment Scheme (EIS). It operates as a subsidiary of IP Group Plc since 2017, with combined net assets of £1.2 billion as of March 2019.

Oxford Nanopore Technologies Limited is a biotechnology company specializing in the development and commercialization of nanopore-based sequencing technology for the analysis of DNA, RNA, proteins, and small molecules. Its innovative product lineup includes the portable MinION device, the benchtop PromethION, and the GridION system, all of which enable real-time data streaming and scalable sequencing for a variety of applications in scientific research, personalized medicine, environmental monitoring, and agriculture. The Flongle offers smaller, on-demand sequencing solutions, catering to users requiring rapid insights. Operating in over 80 countries, Oxford Nanopore's technology is designed for accessibility and ease of use, featuring straightforward library preparation and automated solutions. The company maintains a robust patent portfolio, supporting its ongoing research and development in both biological and solid-state nanopore technologies. Founded in 2005 and based in Oxford, United Kingdom, Oxford Nanopore Technologies also has offices in multiple countries, including the United States, China, and Germany.

AccelerComm Ltd is a semiconductor IP-core company based in Southampton, United Kingdom, specializing in Forward Error Correction (FEC) and channel coding solutions for wireless communications. Founded in 2016, the company develops advanced error correction technologies, including Polar and Turbo Decoders, as well as LDPC encoding and decoding chains, which are compliant with 3GPP standards. These technologies are designed to enhance the performance of next-generation wireless communication systems, addressing challenges such as noise, interference, and poor signal quality. By offering innovative solutions that improve the efficiency and reliability of communication networks, AccelerComm aims to support the evolution of mobile technology beyond 3G and 4G standards.

Cambridge Innovation Capital, established in 2013, is a venture capital firm based in Cambridge, UK. It specializes in early-stage investments, focusing on life sciences and technology companies with affiliations to the University of Cambridge or the Cambridge Cluster. The firm invests in a wide range of sectors, including healthcare, therapeutics, medtech, digital health, genomics, and emerging technologies such as AI, IoT, and quantum technologies. Cambridge Innovation Capital typically invests up to £19 million per company, providing long-term equity finance to support the growth and commercial development of innovative businesses. As a preferred investor for the University of Cambridge, the firm has access to a robust pipeline of investment opportunities within the ecosystem. Since its inception, Cambridge Innovation Capital has raised £275 million to fund disruptive, deep-tech businesses.

Mirriad Advertising, established in 2015 and headquartered in London, specializes in in-video advertising solutions. It uses artificial intelligence and computer vision technology to dynamically insert products and signage into existing video content, creating new advertising inventory for content producers and distributors. This approach enhances viewer engagement and limits commercial interruptions. Mirriad serves clients in the UK, US, China, and other countries, generating the majority of its revenue in the US.

Navenio Limited is a software technology company based in Oxford, United Kingdom, specializing in location-based services for indoor environments through mobile applications. Established in 2015, Navenio's innovative platform enhances indoor localization without the need for additional hardware, such as beacons or Wi-Fi. By utilizing advanced techniques like fingerprinting of the electromagnetic spectrum and indoor mapping, Navenio's solutions enable clients across various sectors, including retail, transportation, venues, and healthcare, to efficiently locate individuals and improve workforce productivity. The company's intelligent workforce solution automates processes based on established best practices, leading to significant enhancements in staff efficiency and operational workflows.

Mixergy Ltd, founded in 2014 and headquartered in Cassington, United Kingdom, specializes in the development of innovative energy storage solutions, particularly hot water tanks. The company's technology is designed to enhance energy efficiency and support the integration of renewable energy sources, such as solar power and heat pumps. By providing a cost-effective means to store and utilize energy, Mixergy aims to facilitate grid balancing and optimize the use of renewable power, contributing to a more sustainable energy landscape.

Ultraleap Limited is a leading developer of mid-air haptic control systems and 3D hand tracking technology. Formerly known as Ultrahaptics, the company specializes in creating solutions that utilize ultrasound to generate tactile sensations, enabling users to feel three-dimensional shapes and textures without physical contact. Its flagship products include the Leap Motion Controller, which captures hand movements, and the VR Developer Mount, designed for enhancing virtual reality experiences on various headsets. The company's innovative technology is applicable across multiple industries such as extended reality, automotive, digital signage, industrial automation, consumer electronics, and location-based entertainment. Established in 2013 and headquartered in Bristol, United Kingdom, Ultraleap also has a subsidiary in Silicon Valley, United States.

BOXARR Limited is a software company based in Bristol, United Kingdom, specializing in systems engineering and supply chain management solutions for both public and commercial sectors. The company offers a comprehensive platform that focuses on modeling interdependencies within organizational systems, enabling effective complexity management and risk mitigation. Its product solutions include collaborative modeling, analysis, optimization, and reporting, catering to various aspects of supply chain design, risk management, and value stream mapping. Additionally, BOXARR provides consultancy services, technical support, and implementation services to enhance the user experience and ensure successful adoption of its solutions. With a strong presence in the aerospace and defense industries, BOXARR aims to help organizations visualize their supply chains and growth processes, ultimately driving profitability and operational efficiency. Established in 2003 and formerly known as Plexus Planning Limited, the company rebranded to BOXARR in May 2015 and operates internationally through a network of Alliance Partners.

Dukosi Ltd is a company that specializes in the design, development, and manufacture of advanced battery management systems, primarily serving the automotive industry. Founded in 2003 and located in Edinburgh, United Kingdom, Dukosi offers innovative cell sensor products tailored for hybrid, plug-in hybrid, and electric vehicles, as well as electric bicycles and mobility solutions. The company's technology enables real-time monitoring of individual battery cell health, contributing to enhanced performance and longevity. Dukosi's solutions are aimed at providing reliable and renewable energy sources for vehicles, transport networks, and various applications, thereby supporting the transition to cleaner energy technologies.

Seren Photonics Limited specializes in the development and manufacture of semi-polar and non-polar Gallium Nitride (GaN) templates, which are essential for light-emitting diodes (LEDs), lasers, vertical-cavity surface-emitting lasers (VCSELs), and power switches. Based in Bridgend, United Kingdom, the company employs a proprietary manufacturing process to produce these templates, specifically growing semi-polar GaN on m-plane sapphire and non-polar GaN on r-plane sapphire. Their innovative technology significantly enhances light intensity in high-brightness LEDs, achieving increases in light generation ranging from 100% to 900% compared to untreated diodes. Founded in 2009, Seren Photonics has positioned itself to serve various lighting markets, including backlighting for laptops and televisions, signage, and architectural lighting. As of November 2016, it operates as a subsidiary of Fusion IP Sheffield Limited.

First Light Fusion Limited is a UK-based company that specializes in researching advanced implosion processes aimed at electricity generation through inertial confinement fusion. Founded in 2011 as a spin-out from the University of Oxford, the company focuses on harnessing fundamental physics to explore various innovative energy generation methods. It employs a team of engineers and physicists who engage in theoretical analysis, detailed numerical simulations, and experimental validation to develop new energy sources. First Light Fusion collaborates closely with several academic institutions, including the University of Oxford, Warwick University, University College London, and Imperial College London. The company, originally named Oxyntix Ltd., rebranded in June 2014 to reflect its focus on fusion energy research.

Avacta Group Plc is a biotechnology company based in the United Kingdom, specializing in the development and provision of reagents and therapeutics utilizing its proprietary Affimer technology. The company operates through three main segments: Diagnostics, Therapeutics, and Animal Health. In the Diagnostics sector, Avacta develops custom Affimer proteins for diagnostic assays, while its Therapeutics segment focuses on innovative cancer immunotherapies that integrate Affimer biotherapeutics with precision tumor-targeted chemotherapy. Additionally, Avacta provides tools and services for the diagnosis of animal health conditions, facilitating quicker treatments for veterinarians. The company has established various research collaborations and partnerships, including with Moderna Therapeutics and LG Chem Life Sciences, to enhance its offerings in biopharmaceutical drug development and clinical diagnostics. Founded in 2003, Avacta continues to expand its reach across North America, Asia, and Europe.

Oxford Nanopore Technologies Limited is a biotechnology company specializing in the development and commercialization of nanopore-based sequencing technology for the analysis of DNA, RNA, proteins, and small molecules. Its innovative product lineup includes the portable MinION device, the benchtop PromethION, and the GridION system, all of which enable real-time data streaming and scalable sequencing for a variety of applications in scientific research, personalized medicine, environmental monitoring, and agriculture. The Flongle offers smaller, on-demand sequencing solutions, catering to users requiring rapid insights. Operating in over 80 countries, Oxford Nanopore's technology is designed for accessibility and ease of use, featuring straightforward library preparation and automated solutions. The company maintains a robust patent portfolio, supporting its ongoing research and development in both biological and solid-state nanopore technologies. Founded in 2005 and based in Oxford, United Kingdom, Oxford Nanopore Technologies also has offices in multiple countries, including the United States, China, and Germany.

Anacail Limited is a technology company based in Glasgow, United Kingdom, founded in 2010. It specializes in the development of innovative ozone-based systems for the sterilization of products within sealed packaging. Anacail's technology generates ozone directly in the final product packaging, effectively oxidizing surface contaminants and eliminating microorganisms without leaving any residual chemicals. This approach not only enhances food safety and extends shelf life but also addresses handling and safety concerns typically associated with ozone use. The company provides equipment for integration into food processing lines, as well as devices for medical sterilization, offering a safe and efficient method for achieving chemical-free sterilization of packaged goods.

Relitect Limited is a technology company based in Motherwell, United Kingdom, focused on developing innovative diagnostic solutions for the life sciences industry. Founded in 2014, Relitect specializes in a novel assay platform that enables label-free electrochemical detection of binding events. This proprietary technology allows for the highly sensitive analysis of proteins, small molecules, and nucleic acids, making it suitable for clinical diagnostics and research applications. By utilizing small sample volumes and a multiplexed format, Relitect's technology minimizes sample interference and eliminates the potential for cross-talk between labeled reagents, enhancing the accuracy of biomarker detection.

Dukosi Ltd is a company that specializes in the design, development, and manufacture of advanced battery management systems, primarily serving the automotive industry. Founded in 2003 and located in Edinburgh, United Kingdom, Dukosi offers innovative cell sensor products tailored for hybrid, plug-in hybrid, and electric vehicles, as well as electric bicycles and mobility solutions. The company's technology enables real-time monitoring of individual battery cell health, contributing to enhanced performance and longevity. Dukosi's solutions are aimed at providing reliable and renewable energy sources for vehicles, transport networks, and various applications, thereby supporting the transition to cleaner energy technologies.

Eight19 Limited, based in Cambridge, United Kingdom, specializes in the development and manufacture of organic photovoltaic (OPV) modules designed for lightweight solar panels. Founded in 2010, the company focuses on providing energy harvesting solutions for various applications, including indoor, outdoor, and off-grid environments. Eight19's innovative use of roll-to-roll manufacturing processes and solution-based organic materials allows for cost-effective scaling of its technology. Their products are particularly suited for the internet of things, wireless devices, and portable electronics, offering benefits such as flexibility, thinness, and robustness. The company also produces integrated demonstration units, including Bluetooth-connected temperature and light sensors powered by its OPV modules, reinforcing its commitment to advancing sustainable energy solutions.

Ultraleap Limited is a leading developer of mid-air haptic control systems and 3D hand tracking technology. Formerly known as Ultrahaptics, the company specializes in creating solutions that utilize ultrasound to generate tactile sensations, enabling users to feel three-dimensional shapes and textures without physical contact. Its flagship products include the Leap Motion Controller, which captures hand movements, and the VR Developer Mount, designed for enhancing virtual reality experiences on various headsets. The company's innovative technology is applicable across multiple industries such as extended reality, automotive, digital signage, industrial automation, consumer electronics, and location-based entertainment. Established in 2013 and headquartered in Bristol, United Kingdom, Ultraleap also has a subsidiary in Silicon Valley, United States.

Intelligent Ultrasound Group is a company specializing in the development, marketing, and distribution of medical training simulators and clinical ultrasound software. Based in Cardiff, United Kingdom, it offers a range of innovative products designed to enhance the quality and reliability of medical ultrasound. Its clinical AI software products, including ScanNav Audit, ScanNav AutoCapture, and ScanNav AnatomyGuide, provide real-time support and automation in ultrasound procedures, such as fetal anomaly scans and the identification of key anatomical structures. The company's training simulators, such as ScanTrainer for obstetrics and gynecology, HeartWorks for cardiac training, and BodyWorks for emergency medicine, are widely used to educate medical professionals. Intelligent Ultrasound Group, which was founded in 2004 and formerly known as MedaPhor Group, has a significant presence in the United Kingdom, North America, and other international markets.

Perpetuum Ltd. is a company based in Southampton, United Kingdom, that specializes in the engineering, manufacturing, and commercialization of electromagnetic vibration harvesting micro generators. Founded in 2004 as a technology spin-off from the University of Southampton, Perpetuum has developed innovative self-powered wireless sensor solutions designed for condition monitoring in various industries, including rail, oil and gas, chemicals, and power generation. Its flagship products convert mechanical vibration into electrical energy, allowing for the operation of autonomous, maintenance-free wireless sensor nodes that transmit critical data on equipment health and performance. Perpetuum is recognized as the global leader in vibration energy harvesting, continually advancing the practical applications of this technology to enhance operational efficiency and safety in industrial environments.

Blooie Limited is a Newcastle upon Tyne-based company that operates an intelligent conversation platform designed for online businesses to facilitate real-time interactions with their customers. Founded in 2011, Blooie's platform enables website owners to engage in informed conversations with users, enhancing customer satisfaction and driving conversion rates. The platform provides real-time analytics and a dashboard that tracks conversion metrics, allowing businesses to assess their customer engagement effectively. Users can communicate with site owners, other Blooie users, or their social media contacts without leaving the website, which helps to keep them engaged longer. By streamlining customer interactions and offering valuable insights, Blooie supports online businesses in improving their overall performance and fostering meaningful connections with their audience.

Oxford Nanopore Technologies Limited is a biotechnology company specializing in the development and commercialization of nanopore-based sequencing technology for the analysis of DNA, RNA, proteins, and small molecules. Its innovative product lineup includes the portable MinION device, the benchtop PromethION, and the GridION system, all of which enable real-time data streaming and scalable sequencing for a variety of applications in scientific research, personalized medicine, environmental monitoring, and agriculture. The Flongle offers smaller, on-demand sequencing solutions, catering to users requiring rapid insights. Operating in over 80 countries, Oxford Nanopore's technology is designed for accessibility and ease of use, featuring straightforward library preparation and automated solutions. The company maintains a robust patent portfolio, supporting its ongoing research and development in both biological and solid-state nanopore technologies. Founded in 2005 and based in Oxford, United Kingdom, Oxford Nanopore Technologies also has offices in multiple countries, including the United States, China, and Germany.

Diurnal Group plc is a specialty pharmaceutical company based in Cardiff, United Kingdom, that specializes in developing hormone therapeutics for the treatment of chronic endocrine conditions. Founded in 2004, the company aims to provide innovative solutions for conditions such as congenital adrenal hyperplasia, adrenal insufficiency, hypogonadism, and hypothyroidism. Diurnal's notable products include Alkindi, a replacement therapy for pediatric adrenal insufficiency, and Chronocort, which has completed Phase III clinical trials for adrenal insufficiency and congenital adrenal hyperplasia. The company is also advancing its early-stage pipeline with products such as Native Oral Testosterone for hypogonadism, a siRNA therapy for adrenocorticotropin-dependent Cushing's syndrome, and a modified-release preparation of T3 hormone for hypothyroidism. Diurnal's research emphasizes circadian-based endocrinology, focusing on physiological treatment regimes to address the needs of patients with rare and chronic endocrine disorders.

Givey Limited operates givey.com, a fee-free online community funding platform dedicated to raising donations for small charities and local communities in the UK. The platform enables users to create fundraising pages that can feature photos, videos, and links from various social media networks, facilitating easy sharing and engagement. It empowers businesses to support their employees' charitable efforts and allows charities to manage their fundraising activities effectively, including overseeing donations and communicating with supporters. With over 7,000 registered charities and a growing user base of more than 100,000 individuals, Givey enhances the digital presence of small charities and local non-profit groups, promoting social good and fostering community resilience. Founded in 1994 and based in London, Givey is committed to making charitable giving more accessible and impactful.

Seren Photonics Limited specializes in the development and manufacture of semi-polar and non-polar Gallium Nitride (GaN) templates, which are essential for light-emitting diodes (LEDs), lasers, vertical-cavity surface-emitting lasers (VCSELs), and power switches. Based in Bridgend, United Kingdom, the company employs a proprietary manufacturing process to produce these templates, specifically growing semi-polar GaN on m-plane sapphire and non-polar GaN on r-plane sapphire. Their innovative technology significantly enhances light intensity in high-brightness LEDs, achieving increases in light generation ranging from 100% to 900% compared to untreated diodes. Founded in 2009, Seren Photonics has positioned itself to serve various lighting markets, including backlighting for laptops and televisions, signage, and architectural lighting. As of November 2016, it operates as a subsidiary of Fusion IP Sheffield Limited.

Oxehealth Ltd. is a technology company based in Oxford, United Kingdom, that specializes in non-contact vital signs monitoring. Founded in 2012, it has developed the Oxecam software, which allows for the remote measurement of heart rate, respiratory rate, and blood oxygenation using digital video cameras. This innovative approach is particularly beneficial in medical settings, where it can enhance care for elderly and vulnerable individuals in environments where staff presence is limited. The system generates alerts for risky activities and provides objective data on patient vitals, enabling informed care planning. Oxehealth's technology combines proprietary algorithms that leverage deep learning, computer vision, and signal processing, making it suitable for various sectors, including healthcare, security, and retail. Its Digital Care Assistant supports clinicians and caregivers in mental health facilities, prisons, and home care, facilitating proactive interventions based on real-time data. Oxehealth is recognized for achieving the world’s first medical device certification for its software, demonstrating its commitment to enhancing patient care through innovative technology.

Creavo Medical Technologies Ltd. is a UK-based medical device company focused on developing innovative imaging technologies for acute medical settings. Incorporated in 2014, the company has its headquarters in Coventry and additional facilities in Leeds. Creavo specializes in creating portable, battery-powered devices that utilize magnetocardiography to detect heart-related issues, such as acute coronary syndromes and ischemia, directly at the patient's bedside. Founded by a team of clinical, research, and business experts, the company aims to improve diagnostic techniques and enhance patient outcomes in healthcare settings. Creavo Medical Technologies was previously known as Quantum Imaging Limited before rebranding in September 2016.

Blooie Limited is a Newcastle upon Tyne-based company that operates an intelligent conversation platform designed for online businesses to facilitate real-time interactions with their customers. Founded in 2011, Blooie's platform enables website owners to engage in informed conversations with users, enhancing customer satisfaction and driving conversion rates. The platform provides real-time analytics and a dashboard that tracks conversion metrics, allowing businesses to assess their customer engagement effectively. Users can communicate with site owners, other Blooie users, or their social media contacts without leaving the website, which helps to keep them engaged longer. By streamlining customer interactions and offering valuable insights, Blooie supports online businesses in improving their overall performance and fostering meaningful connections with their audience.

Actual Experience plc is an analytics-as-a-service company based in Bath, United Kingdom, specializing in human experience management and consultancy services. The company offers a cloud-based analytics platform that gathers data from digital users, applying algorithms to produce objective quality scores for digital experiences and supply chain diagnostics. Its primary product includes a Dashboard that delivers actionable insights to help service providers identify issues affecting digital quality. Actual Experience's services are designed to enhance the digital ecosystem for organizations by integrating technology, operations, and employee experience data. The company segments its offerings into three main products: Actual Work, Actual Home, and Actual Work Web, each tailored to analyze different aspects of digital service delivery. Actual Experience operates in both the United Kingdom and the United States.

Exonate Limited is a privately held biotech company founded in 2013 and based in Duxford, United Kingdom, with a research and development laboratory in Nottingham. The company specializes in the discovery and development of small molecule drugs that target alternative messenger RNA splicing, particularly in the field of ophthalmology. Exonate's lead program focuses on diabetic macular oedema (DMO) and wet age-related macular degeneration (wAMD), significant causes of vision loss. The company has developed a pipeline of novel small molecule inhibitors, known as SPHINXes, which selectively inhibit the production of pro-angiogenic vascular endothelial growth factor (VEGF) through the modulation of serine/threonine-protein kinase 1 (SRPK1)-mediated splicing. These inhibitors have shown promising efficacy in preclinical models as topical agents for treating these retinal disorders. Exonate is backed by a strong scientific foundation and leadership team, with connections to academic expertise at the University of Nottingham. The company is advancing its drug candidates through regulatory studies aimed at clinical evaluation.

Verticly, established in 2014 and headquartered in London, offers a SaaS platform that bridges online and offline customer data for FMCG brands, retailers, and manufacturers. It specializes in omni-channel marketing, enabling real-time, personalized engagement with consumers. The platform facilitates data exchange, channel attribution, vouchering, and targeted messaging, driving purchase decisions and enhancing customer experiences.

Oxford Nanopore Technologies Limited is a biotechnology company specializing in the development and commercialization of nanopore-based sequencing technology for the analysis of DNA, RNA, proteins, and small molecules. Its innovative product lineup includes the portable MinION device, the benchtop PromethION, and the GridION system, all of which enable real-time data streaming and scalable sequencing for a variety of applications in scientific research, personalized medicine, environmental monitoring, and agriculture. The Flongle offers smaller, on-demand sequencing solutions, catering to users requiring rapid insights. Operating in over 80 countries, Oxford Nanopore's technology is designed for accessibility and ease of use, featuring straightforward library preparation and automated solutions. The company maintains a robust patent portfolio, supporting its ongoing research and development in both biological and solid-state nanopore technologies. Founded in 2005 and based in Oxford, United Kingdom, Oxford Nanopore Technologies also has offices in multiple countries, including the United States, China, and Germany.

Ubiquigent Limited is a biotechnology company based in Dundee, United Kingdom, founded in 2009. It specializes in the development and supply of high-quality reagents, kits, and drug discovery assay development services, focusing on the ubiquitin and ubiquitin-like signaling systems. The company provides protein degradation-focused drug discovery services and designs novel deubiquitylase (DUB) enzyme inhibitors as potential therapeutics for addressing unmet medical needs. Ubiquigent collaborates with both academic and pharmaceutical researchers, supporting fundamental scientific discovery and the exploration of innovative drug candidates targeting DUBs. Its hybrid business model emphasizes the generation of intellectual property while maintaining an internal pipeline of drug discovery programs aimed at optimizing compounds for critical therapeutic areas.

Blooie Limited is a Newcastle upon Tyne-based company that operates an intelligent conversation platform designed for online businesses to facilitate real-time interactions with their customers. Founded in 2011, Blooie's platform enables website owners to engage in informed conversations with users, enhancing customer satisfaction and driving conversion rates. The platform provides real-time analytics and a dashboard that tracks conversion metrics, allowing businesses to assess their customer engagement effectively. Users can communicate with site owners, other Blooie users, or their social media contacts without leaving the website, which helps to keep them engaged longer. By streamlining customer interactions and offering valuable insights, Blooie supports online businesses in improving their overall performance and fostering meaningful connections with their audience.

Xeros Technology Group plc specializes in developing and commercializing polymer-based technologies aimed at reducing water usage in cleaning processes across various sectors, including fabric and garment manufacturing, as well as industrial and domestic laundry. The company has created innovative products such as XOrbs, which utilize polymer technology to effectively remove dirt and stains with minimal water, and XDrum, designed for fabric and garment manufacturing applications. Additionally, it offers XFiltra, a system that facilitates the easy disposal of collected fibers by de-watering filtered materials. Originating from research by Professor Stephen Burkinshaw at the University of Leeds, Xeros's patented polymer bead cleaning system demonstrates significant potential for cost savings and environmental benefits in commercial laundry and other industries like leather processing and metal cleaning. Based in Rotherham, United Kingdom, Xeros continues to expand its operations in Europe and North America.

Givey Limited operates givey.com, a fee-free online community funding platform dedicated to raising donations for small charities and local communities in the UK. The platform enables users to create fundraising pages that can feature photos, videos, and links from various social media networks, facilitating easy sharing and engagement. It empowers businesses to support their employees' charitable efforts and allows charities to manage their fundraising activities effectively, including overseeing donations and communicating with supporters. With over 7,000 registered charities and a growing user base of more than 100,000 individuals, Givey enhances the digital presence of small charities and local non-profit groups, promoting social good and fostering community resilience. Founded in 1994 and based in London, Givey is committed to making charitable giving more accessible and impactful.

Magnomatics Limited is a technology engineering company based in Sheffield, United Kingdom, founded in 2006 as a spin-out from the University of Sheffield. Specializing in proprietary magnetic gear technology, Magnomatics develops innovative products such as the Pseudo Direct Drive, a high torque low-speed motor and generator suitable for various applications including actuation, fan motors, marine propulsion, and wind power. Additionally, the company offers MAGSPLIT, a power-split continuously variable transmission solution designed for blended hybrid powertrains and ancillary drives. Serving diverse sectors such as oil and gas, automotive, aerospace, marine propulsion, renewable energy, and rail traction, Magnomatics aims to provide efficient alternatives to traditional mechanical gears, thereby lowering operating costs and reducing carbon emissions in the transport and energy industries.